Cargando…
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
Autor principal: | Lorenc, Z. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636566/ http://dx.doi.org/10.1097/01.GOX.0000526445.68948.be |
Ejemplares similares
-
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
por: Lorenc, Z. Paul
Publicado: (2017) -
Abstract: Treatment of Asymmetries and Sequelae of Facial Paralysis by Using Botulinum Toxin
por: Evin, Nuh, et al.
Publicado: (2017) -
Abstract: A Randomized Placebo-Controlled Double Blind Study of Intercostal Nerve Block Versus Incisional Infiltration with Bupivacaine for Postoperative Pain Control after Subpectoral Breast Augmentation
por: Numhom, Surawej, et al.
Publicado: (2017) -
Abstract: The Use of Nanofat in Androgenic Alopecia. a Prospective Blinded Study
por: Vestita, Michelangelo, et al.
Publicado: (2017) -
Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty
por: Bindewald, Matthew, et al.
Publicado: (2017)